Fig. 3

Prognosis analysis of the 14-lncRNAs prognostic model in the training set and the testing set. Distribution of risk score based on the sixteen-gene model in the training set (A) and the testing set (D). Patterns of survival status and survival time of each patient in the training set (B) and the testing set (E). Expression pattern of sixteen genes of each patient in the training set (C) and the testing set (F). Kaplan-Meier survival curves of the OS of patients in the high- and low-risk groups in the training set (G) and the testing set (H). ROC curve of 1-year, 3-year, and 5-year overall survival in the training set (I) and the testing set (J)